RecruitingNCT05779215
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
The Multicenter, Prospective, Real-world Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
Sponsor
Xuanwu Hospital, Beijing
Enrollment
50,000 participants
Start Date
Apr 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.
Eligibility
Inclusion Criteria2
- The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018)
- Informed consent from the patient or surrogate
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERVisit at D90
Visits at 90±7 days after stroke onset were conducted by trained and blinded investigators, with face-to-face, telephone call or Internet access.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05779215
Related Trials
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT0568664228 locations
Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion
NCT059035601 location
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
NCT064407073 locations
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
NCT061434881 location
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302224 locations